BRITNEY OHSE: Open Payments
NPI 1376290742 · PARKERSBURG, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,006 in 61 payments from 9 companies in 2025. Trend: 2023 $1,005 · 2024 $758 · 2025 $1,006
Food & beverage: $1,006
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 14 | $271 |
| ABBVIE INC. | 18 | $209 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $151 |
| Janssen Pharmaceuticals, Inc | 5 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $98 |
| Lundbeck LLC | 3 | $70 |
| Vanda Pharmaceuticals Inc. | 2 | $39 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $22 |
Products named: REXULTI, VRAYLAR, CAPLYTA, SPRAVATO, TRINTELLIX, ABILIFY MAINTENA, ABILIFY ASIMTUFII, FANAPT.
Industry payments across WV — which companies pay providers there.
